New sulphates of xylans molecular low weight, their process of preparation and their antithrombotic activity and hypolipémiante for oral use

摘要

The present invention relates to novel xylan sulfates of average molecular weight comprised between 2000 and 5000 Daltons. The invention also relates to their process of preparation by fractionation and their use in therapeutics as orally active antithrombotic and hypolipaemic agents.